期刊
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
卷 5, 期 8, 页码 917-920出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2007.04.014
关键词
-
Erlotinib is a tyrosine kinase inhibitor recently approved by the Food and Drug Administration for the treatment of non-small-cell lung cancer and pancreatic cancer. We report a case of a patient with stage IV non-small-cell lung cancer who died of fulminant hepatic failure as a result of treatment with erlotinib.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据